Intestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study

Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi

Intest Res. 2021;19(3):301-312. Published online August 20, 2020
DOI: https://doi.org/10.5217/ir.2020.00013

Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study

Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi

Intestinal Research. 2021;19(3):301-312

Link1

Link2 Link3

Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study

Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi

Intestinal Research. 2021;19(4):408-418

Link1

Link2 Link3

Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study

Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi

Intestinal Research. 2021;19(4):419-429

Link1

Link2 Link3

Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study

Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco, Stefano Gentileschi, Elena Silvestri, Claudia Fabiani, Maria Letizia Urban, Bruno Frediani, Mauro Galeazzi, Florenzo Iannone, Donato Rigante, Luca Cantarini

Clinical Rheumatology. 2016;36(2):451-455

Link1

Link2 Link3

Long-term safety and efficacy of subcutaneous pasireotide in patients with Cushing’s disease: interim results from a long-term real-world evidence study

Luca Manetti, Timo Deutschbein, Jochen Schopohl, Kevin C. J. Yuen, Michael Roughton, Ulrike Kriemler-Krahn, Libuse Tauchmanova, Ricardo Maamari, Carla Giordano

Pituitary. 2019;22(5):542-551

Link1

Link2 Link3

OC.02.8 A PROSPECTIVE “REAL LIFE” STUDY ON ADALIMUMAB EFFICACY IN STEROID-DEPENDENT CROHN'S DISEASE PATIENTS: RESULTS FROM A LONG TERM FOLLOW-UP

A. Orlando, S. Renna, M. Cappello, R. Di Mitri, F. Mocciaro, M. Mazza, M. Giunta, M. Mendolaro, A. Craxì, M. Cottone

Digestive and Liver Disease. 2016;48:e78

Link1 Link2

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet’s disease

Giuseppe Lopalco, Vincenzo Venerito, Luca Cantarini, Giacomo Emmi, Domenico Prisco, Florenzo Iannone

Internal and Emergency Medicine. 2018;14(5):719-722

Link1

Link2 Link3

Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients

Masayoshi Harigai, Tsuyoshi Tsuchiya, Katsuyoshi Kawana, Sarina Kurimoto

Modern Rheumatology. 2017;28(1):30-38

Link1 Link2

Adalimumab long-term safety/efficacy results for pediatric patients with chronic plaque psoriasis from a phase 3, randomized study

Journal of the American Academy of Dermatology. 2016;74(5):AB209

Link1 Link2

Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice

Ken Sugimoto, Kentaro Ikeya, Masaichi Kato, Ai Matsuura, Fumitoshi Watanabe, Ryosuke Takano, Satoshi Tamura, Shinya Tani, Satoshi Osawa, Hiroyuki Hanai

Digestive Diseases. 2018;37(1):11-20

Link1 Link2